ENL 46.54 Reed Elsevier Nv $ENL Hit a 52 week high of 46.54

New Post Public Reply Private Reply Replies (0) Message Board

Nov 17, 2014 at 10:48 AM

ENL 46.54 Reed Elsevier Nv $ENL Hit a 52 week high of 46.54 Closing the day 09:43 at 46.54 -0.23 -0.49% With a day low of 46.48 and a total volume of 5,990.

ENL Recent Posts: http://investorshangout.com/Reed-Elsevier-NV-ENL-50879/

ENL Reed Elsevier Nv Recent Headline News

Elsevier Expands Neuroscience Portfolio With Eight New Books
Marketwire Canada - 2 hrs 2 mins ago
Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the expansion of its neuroscience portfolio with eight new neuroscience books. These include the long-awaited fourth edition of The Rat Nervous System, edited by award-winning researcher, professor and author Dr. George Paxinos. The book's completely revised and updated content extends its reputation as the gold-standard reference for rat neuroanatomy. These and other books in its neuroscience portfolio are on display at Elsevier booth #115 at the Society for Neuroscience (SfN) annual meeting in Washington, DC, November 16-19.
RUK: 66.12 (+0.07), ENL: 46.79 (+0.02)

Elsevier Publishes Four New Books in Environmental Sciences Portfolio
Marketwired - Wed Nov 12, 3:00AM CST
Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the publication of four new environmental science books offering the latest information on the study of soil and water, including the fourth edition of Soil Microbiology, Ecology and Biochemistry, written by Eldor Paul, Senior Research Scientist at the Natural Resources Ecology Laboratory at Colorado State University, Fort Collins, and Professor Emeritus at Michigan State University.
RUK: 66.12 (+0.07), ENL: 46.79 (+0.02)

Sentrian, the World's First Remote Patient Intelligence Company, Launches to Eliminate Preventable Hospitalization
PR Newswire - Mon Nov 10, 7:03AM CST
Sentrian(TM) (formally Jointly Health), the Remote Patient Intelligence(TM) company aspiring to eliminate all preventable hospitalization, formally launched today at Singularity University's Exponential Medicine Conference.
RUK: 66.12 (+0.07), IBM: 164.23 (+0.07), ENL: 46.79 (+0.02)

LexisNexis: Homegrown Cardiff Company, Tracesmart(R), Creates 40 New Jobs in Cardiff
Business Wire - Wed Oct 15, 8:02AM CDT
Tracesmart, a company founded and headquartered in Cardiff, Wales, will be creating 40 jobs by the end of the year, increasing employee numbers by more than 50 percent. The new roles, based in Cardiff, include highly skilled IT developers and engineers and will support Tracesmart as it becomes the U.K. center of excellence for LexisNexis(R) Risk Solutions which acquired the company in April 2014. For more than 12 years, LexisNexis Risk Solutions has been one of the fastest-growing divisions and a key area of strategic focus of its parent company, Reed Elsevier(R), one of the world's leading providers of digital content and professional information solutions.
RUK: 66.12 (+0.07), ENL: 46.79 (+0.02)

Will John Wiley Gain from Transition to Digital Media? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Sep 26, 11:20AM CDT
John Wiley & Sons (JW.A) is transitioning to digitization due to soft demand for print media and recent acquisitions have a vital role to play in this. Inorganic expansion is being pursued aggressively at John Wiley and is yielding positive results as evident from the company???s first quarter fiscal 2015 results.
SCHL: 34.70 (-0.10), ENL: 46.79 (+0.02), SSP: 19.25 (+0.09), JW.A: 59.52 (+0.41)

Elsevier Publishes New Content on Graphene and Materials Science
Marketwire Canada - Thu Sep 25, 3:00AM CDT
Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the publication of new content on graphene and materials science, including Graphene: Properties, Preparation, Characterisation and Devices by Viera Skakalova and Alan Kaiser. Carbon nanotubes, graphene and nanomaterials are emerging and increasingly important materials with many applications in medicine, computing, optics, energy and materials science.
RUK: 66.12 (+0.07), ENL: 46.79 (+0.02)

Elsevier Publishes New Books on Bone and Endocrine Disease
Marketwire Canada - Thu Sep 11, 3:54AM CDT
Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the publication of four new books on bone and endocrine disease, including Bone Cancer, 2nd Edition: Primary Bone Cancers and Bone Metastases by Dominique Heymann. These biomedical science books will be on display in Elsevier's booth #101 at the upcoming American Society for Bone and Mineral Research (ASBMR) 2014 Annual Meeting, September 12-15 in Houston, TX.
RUK: 66.12 (+0.07), ENL: 46.79 (+0.02)

John Wiley Beats Q1 Earnings on Strategic Acquisitions - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Sep 10, 9:00AM CDT
John Wiley & Sons Inc. (JW-A) reported first-quarter fiscal 2015 adjusted earnings per share of 56 cents that topped the Zacks Consensus Estimate while rising 10% year over year driven by acquisitions.
SCHL: 34.70 (-0.10), ENL: 46.79 (+0.02), JW.A: 59.52 (+0.41)

Elsevier Publishes New Chemical Engineering Content
Marketwire Canada - Wed Sep 03, 3:00AM CDT
Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced that new chemical engineering content is available. This content includes three new books on industrial distillation and two additional books on flow analysis and water reclamation. These books provide researchers and graduate students with latest knowledge required for those working in the oil, petrochemical, chemical, pharmaceutical and environmental industries.
RUK: 66.12 (+0.07), ENL: 46.79 (+0.02)

Elsevier to Market Innovative Patient Data Collection Platform from Tonic Health
PR Newswire Europe - Tue Sep 02, 11:24AM CDT
PHILADELPHIA, Pennsylvania, September 2, 2014 /PRNewswire/ --
RUK: 66.12 (+0.07), ENL: 46.79 (+0.02)

Elsevier Announces the Launch of Open Access Journal: 'Neurobiology of Stress'
PR Newswire Europe - Thu Aug 14, 7:19AM CDT
OXFORD, England, August 14, 2014 /PRNewswire/ --
RUK: 66.12 (+0.07), ENL: 46.79 (+0.02)

Elsevier Announces 2013 Journal Impact Factor Highlights
PR Newswire Europe - Thu Aug 14, 7:03AM CDT
AMSTERDAM, August 14, 2014 /PRNewswire/ --
RUK: 66.12 (+0.07), ENL: 46.79 (+0.02)

Elsevier Publishes First Edition of Non-Operating Room Anesthesia
PR Newswire Europe - Fri Aug 01, 6:42AM CDT
PHILADELPHIA, August 1, 2014 /PRNewswire/ --
RUK: 66.12 (+0.07), ENL: 46.79 (+0.02)

Elsevier Announces the Launch of Open Access Journal: Oral and Maxillofacial Surgery Cases
PR Newswire Europe - Mon Jul 28, 8:28AM CDT
NEW YORK, July 28, 2014 /PRNewswire/ --
RUK: 66.12 (+0.07), ENL: 46.79 (+0.02)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Alaska's Insurance Maze: Coverage Over Cheap Policies

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Tony Perkins' Church Tour amid Controversial Vote

Lining the pews in Missouri and Kansas, folks are about to get a powerful dose of Tony Perkins this weekend. The Family Research Council President is driving straight into the heart of both spiritual and political fervor at a couple of church stops on Sunday, October 25—right on the doorstep of a crucial vote in Missouri. Taking the Stage in a Time of Tension Now,...

CapCut's AI Tools Reshape Video Content Creation

AI Revolution in Marketing Content: CapCut Takes Lead It's like the old guard of marketing has hitched a ride on a rocket. In 2026, CapCut has stomped into the limelight with Better Business Advice giving them a nod for their prowess in AI-driven content creation. This isn't some passing trend; it's a seismic shift in how businesses craft their messages. CapCut ain't just...

What to Expect: Your First Therapy Session Insights

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Duolingo Faces Class Action: Deadline Looms for Plaintiffs

Shaking up the education sector like a hot potato, investors have been thrown for a loop with Duolingo’s latest legal debacle. News broke that Kahn Swick & Foti, LLC, with significant backing from their heavyweight partner and former Louisiana Attorney General Charles C. Foti Jr., is spearheading a class action lawsuit against Duolingo, Inc. (NasdaqGS: DUOL). It’s one...

COhatch Preps for High-Stakes Ohio Pitch Contest

Ohio Startups Gear Up for Another Fierce Faceoff You wouldn't find me betting against a hungry entrepreneur, especially with $25,000 on the line. That's the prize dangling at this year's Dublin Pitch Competition, hosted by COhatch and the City of Dublin. If there's one thing I'm certain of, it's that Ohio will see some real contenders stepping up on October 15....

Chemours Faces Class Action Over Fraud Allegations

Chemours and the Aftermarket Mirage When it rains, it pours, and for Chemours, the forecast isn't looking sunny. Investors are gearing up to slap Chemours Company (NYSE: CC) with a securities fraud class action. Why, you ask? Overstatement of aftermarket demand for refrigerants left investors high and dry after stock prices took an 18% nosedive. On August 4, 2026,...

Axon Body 5: A Leap Forward in AI for Public Safety

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Gildan Faces Lawsuit: Allegations of Deceptive Practices Shake Investors

Gildan's Troubles Unveiled The financial jungle can be a pretty treacherous place, and Gildan Activewear Inc. (NYSE: GIL) just found out how fickle the market can be. An 18.7% nosedive in Gildan's stock price after a securities fraud class action came knocking—if that isn't enough to stir up a hornet’s nest among investors, I don’t know what is. The Catalyst:...

Lunit, Summit Tackle Tumor Analysis with AI Platform

Amid whispers of AI revolutionizing every industry, let's zero in on its latest pit stop—oncology R&D. Lunit, shaking hands with Summit Therapeutics, plans to bring artificial intelligence into the tumor microenvironment analysis game, thanks to the Lunit SCOPE IO platform. This isn't just another lab experiment; it's a step towards redefining how we understand cancer's...